News
With these advances, 10x Genomics is addressing the growing demand ... GEM-X Universal 3' Gene Expression Multiplex is compatible with Chromium Xo and X instruments. GEM-X Universal 5' Gene ...
Chromium Xo: Last month, 10x Genomics announced the launch of Chromium Xo, the company's most affordable single cell instrument. Chromium Xo delivers the high-quality data, superior ...
10x Genomics has launched two new products from ... The most recently announced Chromium instrument—Chromium Xo, launched in September—is designed to run 10x’s GEM-X 3′ assay and deliver ...
Hosted on MSN3mon
10x Genomics, Inc. (NASDAQ:TXG) Q4 2024 Earnings Call Transcript10x Genomics, Inc. (NASDAQ ... can now get down to $600 per sample at any scale. We also launched Chromium Xo, an instrument that provides a low cost entry point so more researchers can access ...
The introduction of the affordable Chromium Xo product could significantly benefit 10x Genomics in the current economic climate. As research institutions and biotechnology companies face budget ...
For the quarter ended March 2025, 10x Genomics (TXG) reported revenue of ... Revenues- Instruments- Chromium: $5.91 million versus $6.46 million estimated by two analysts on average.
PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results